Antibody shows weight loss, insulin benefits in study

11/28/2012 | U.S. News & World Report

A newly developed antibody called mimAb1, which mimics the function of a naturally occurring molecule called fibroblast growth factor 21, helped induce weight loss and improve insulin sensitivity and BMI in obese monkeys, researchers reported in Science Translational Medicine. However, researchers said it is still unclear how the treatment would work in human patients.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA